Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.

Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM.

Biochem Biophys Res Commun. 2006 Apr 21;342(4):1228-32. Epub 2006 Feb 24.

PMID:
16516163
2.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
3.

Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.

Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM.

Cancer Res. 2004 Jul 15;64(14):4717-20.

4.

Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.

Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM.

Biochem Biophys Res Commun. 2006 Mar 10;341(2):635-40. Epub 2006 Jan 17.

PMID:
16427602
5.

Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.

Kohno H, Amatya VJ, Takeshima Y, Kushitani K, Hattori N, Kohno N, Inai K.

Oncol Rep. 2010 Aug;24(2):423-31.

PMID:
20596629
6.

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Jan 15;12(2):383-91.

7.

Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.

He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N, Mazieres J, Mikami I, McCormick F, Jablons DM.

Cancer Res. 2005 Feb 1;65(3):743-8.

8.

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, García JM, Muñoz A, Esteller M, González-Sancho JM.

Oncogene. 2006 Jul 6;25(29):4116-21. Epub 2006 Feb 20.

PMID:
16491118
9.

Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.

Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablons DM, You L.

Oncol Rep. 2009 Dec;22(6):1479-84.

PMID:
19885602
10.

Downregulation of WIF-1 by hypermethylation in astrocytomas.

Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J, Wang Y, Song T, Zeng F, Rao Y.

Acta Biochim Biophys Sin (Shanghai). 2010 Jun 15;42(6):418-25.

11.

[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].

Qi J, Zhu YQ, Luo J, Tao WH.

Zhonghua Yi Xue Za Zhi. 2007 Jul 24;87(28):1954-7. Chinese.

PMID:
17923031
12.

Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.

Trifa F, Karray-Chouayekh S, Jmal E, Jmaa ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.

Tumour Biol. 2013 Jun;34(3):1625-33. doi: 10.1007/s13277-013-0694-2. Epub 2013 Feb 16.

PMID:
23417837
13.

WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.

Yang TM, Leu SW, Li JM, Hung MS, Lin CH, Lin YC, Huang TJ, Tsai YH, Yang CT.

J Cancer Res Clin Oncol. 2009 Jul;135(7):919-24. doi: 10.1007/s00432-008-0527-7. Epub 2008 Dec 16.

PMID:
19085002
14.

Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.

Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R.

Cancer Res. 2009 Nov 15;69(22):8603-10. doi: 10.1158/0008-5472.CAN-09-2534. Epub 2009 Nov 3.

15.

Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.

Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, Herman JG.

Oncogene. 2010 Nov 4;29(44):5923-34. doi: 10.1038/onc.2010.322. Epub 2010 Aug 9.

16.

Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.

Clément G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto J, Benhattar J, Jablons D.

Cancer Sci. 2008 Jan;99(1):46-53. Epub 2007 Nov 13.

17.

Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.

Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J, Wang Y.

J Exp Clin Cancer Res. 2010 Mar 24;29:26. doi: 10.1186/1756-9966-29-26.

18.

Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.

Tan M, Wu J, Cai Y.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):673-9. doi: 10.1016/j.bbrc.2013.07.123. Epub 2013 Aug 9.

PMID:
23939044
19.

Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.

Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM.

Oncogene. 2004 Aug 26;23(39):6672-6.

PMID:
15221014
20.

Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.

Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM.

Cancer Res. 2003 Aug 1;63(15):4547-51.

Items per page

Supplemental Content

Write to the Help Desk